Feilan Chen
Impact in
- Ophthalmology top 5%
- Ocular Diseases and Behçet’s Syndrome
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- S100 Proteins and Annexins 2
-
- Ocular Diseases and Behçet’s Syndrome 9
- Co-authors
- Zhaohua Tang (6 shared papers)Zili Liu (5 shared papers)Yan Chen (1 shared paper)Jie Gao (1 shared paper)Yongguo Li (1 shared paper)Shengping Hou (6 shared papers)Peizeng Yang (4 shared papers)Zhengxuan Jiang (3 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Journal of Neuro-Oncology (2 papers)Scientific Reports (1 paper)Biological Trace Element Research (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Feilan Chen
23 papers receiving 408 citations
Peers
Comparison fields: 5 of 81
- Ophthalmology 75
- Cancer Research 114
- Rheumatology 50
- Biological Psychiatry 8
- Molecular Biology 211
Countries citing papers authored by Feilan Chen
This map shows the geographic impact of Feilan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feilan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feilan Chen more than expected).
Fields of papers citing papers by Feilan Chen
This network shows the impact of papers produced by Feilan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feilan Chen. The network helps show where Feilan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Feilan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 169 | |
| 2 | 2021 | 37 | |
| 3 | 2012 | 34 | |
| 4 | 2011 | 30 | |
| 5 | 2008 | 23 | |
| 6 | 2020 | 20 | |
| 7 | 2022 | 19 | |
| 8 | 2020 | 16 | |
| 9 | Polymorphisms of IL23R and Fuchs' syndrome in a Chinese Han population. | 2010 | 13 |
| 10 | 2016 | 10 | |
| 11 | 2010 | 8 | |
| 12 | 2016 | 7 | |
| 13 | 2022 | 4 | |
| 14 | CD40 polymorphisms in Han Chinese patients with Fuch uveitis syndrome. | 2011 | 4 |
| 15 | [Blocking ERK signaling pathway lowers MMP-9 expression to alleviate brain edema after traumatic brain injury in rats]. | 2020 | 3 |
| 16 | PRKCQ rs4750316 is associated with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. | 2019 | 3 |
| 17 | 2020 | 3 | |
| 18 | 2018 | 2 | |
| 19 | 2020 | 1 | |
| 20 | 2016 | 1 |
About Feilan Chen
Feilan Chen is a scholar working on Molecular Biology, Ophthalmology, Epidemiology, Rheumatology and Immunology, having authored 25 papers that have together received 410 indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (9 papers), Cytomegalovirus and herpesvirus research (4 papers), Systemic Lupus Erythematosus Research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Research and Treatments (2 papers), Erythropoietin and Anemia Treatment (2 papers), Otitis Media and Relapsing Polychondritis (2 papers) and S100 Proteins and Annexins (2 papers). The work is most often cited by research in Ophthalmology (75 citations), Cancer Research (114 citations), Rheumatology (50 citations), Biological Psychiatry (8 citations) and Molecular Biology (211 citations). Feilan Chen has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Zhaohua Tang, Zili Liu, Yan Chen, Jie Gao, Yongguo Li, Shengping Hou, Peizeng Yang, Zhengxuan Jiang, Fuzhen Li and Qinmeng Shu. Their work appears in journals such as Frontiers in Immunology, Journal of Neuro-Oncology, Scientific Reports, Biological Trace Element Research and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.